Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Digestive System Neoplasms × pemigatinib × 1 year × Clear all

Sponsor

Conditions

Cholangiocarcinoma 5 Acrocephalosyndactylia 5 Carcinoma, Transitional Cell 4 Neoplasm Metastasis 3 Recurrence 2 Urinary Bladder Neoplasms 1 Solid Tumor, Miscellaneous 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms, Unknown Primary 1 Myeloproliferative Disorders 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Leukemia, Myeloid, Acute 1 Glioma 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Eosinophilia 1 Endometrial Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Bevacizumab 4 Irinotecan 2 Cetuximab 2 Ascorbic Acid 2 tislelizumab 1 ribociclib 1 repotrectinib 1 pralsetinib 1 palbociclib 1 olaparib 1 fludarabine 1 encorafenib 1 durvalumab 1 dostarlimab 1 atezolizumab 1 Stem Cell Transplantation 1 Sirolimus 1 Ramucirumab 1 Radiotherapy 1 Paclitaxel 1 Oxaliplatin 1 Melphalan 1 Lutetium-177 1 Lutetium 1 Levoleucovorin 1 Leucovorin 1 Immunotherapy 1 Imatinib Mesylate 1 Hyperthermic Intraperitoneal Chemotherapy 1 Fulvestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡